Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMIX

Autonomix Medical Inc

10.04

Aug 07 • 3:59 PM ET -2.13 (-17.50%)

9.76

Aftermarket • 5:18 PM ET -0.28 (-2.79%)

Healthcare Medical Devices USA Nano NASD

Today, 12:03 PMPullback after patent surge and dilution filing drives AMIX 21% lower

Peers: HSCS NXL BMRA INBS TNON XAIR AEMD IVF NUWE VTAK

Scroll to Statements

Index	-
Market Cap	9.75M
Enterprise Value	2.75M
Income	-16.71M
Sales	0.00M
Book/sh	10.85
Cash/sh	7.21
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jan 29, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.93
P/C	1.39
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	4.45
Current Ratio	4.45
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / No

EPS (ttm)	-64.03
EPS next Y	-19.53
EPS next Q	-6.41
EPS this Y	53.45%
EPS next Y	13.89%
EPS next 5Y	29.01%
EPS past 3/5Y	-3.02% 35.84%
Sales past 3/5Y	- -
EPS Y/Y TTM	62.20%
Sales Y/Y TTM	-
EPS Q/Q	81.71%
Sales Q/Q	-
Earnings	Jun 03
EPS/Sales Surpr.	0.00% -

Insider Own	7.59%
Insider Trans	0.00%
Inst Own	1.79%
Inst Trans	1.69%
ROA	-192.06%
ROE	-238.89%
ROIC	-283.55%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	68.80%
SMA50	45.31%
SMA200	-4.53%
Trades

Shs Outstand	0.97M
Shs Float	0.90M
Short Float	6.85%
Short Ratio	0.02
Short Interest	0.06M
52W High	32.55 -69.16%
52W Low	2.44 311.48%
Volatility	103.90% 39.13%
ATR (14)	2.80
RSI (14)	56.40
Beta	-0.14
Rel Volume	0.22
Avg Volume	3.74M
Volume	806,946

Perf Week	191.86%
Perf Month	55.42%
Perf Quarter	25.02%
Perf Half Y	35.21%
Perf YTD	-13.07%
Perf Year	-61.44%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	58.80
Prev Close	12.17
Price	10.04
Change %	-17.50%

Aug-04-26 11:24AM	Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion (InvestorsHub) +434.25%
08:15AM	Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy (GlobeNewswire)
Jul-24-26 08:47AM	Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study (GlobeNewswire) -16.57%
Jul-23-26 07:30AM	Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform (GlobeNewswire) -12.06%
Jul-15-26 08:00AM	Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform (GlobeNewswire)
09:30PM	Loading…
Jul-13-26 09:30PM	Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -12.48% -9.74%
07:30AM	Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant (GlobeNewswire)
Jun-22-26 08:00AM	Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change (GlobeNewswire)
Jun-18-26 04:30PM	Autonomix Announces Reverse Stock Split (GlobeNewswire) -6.38%
Jun-10-26 09:05AM	Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology (GlobeNewswire) -6.47%
Jun-04-26 09:05AM	Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine (GlobeNewswire)
May-19-26 08:30AM	Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation (GlobeNewswire) -10.00%
May-18-26 08:45AM	Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation (GlobeNewswire)
Apr-29-26 08:45AM	Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation (GlobeNewswire) -6.66%
Apr-22-26 08:42AM	Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 (GlobeNewswire)
08:40AM	Loading…
Apr-08-26 08:40AM	Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 (GlobeNewswire)
Mar-11-26 08:40AM	Autonomix Medical to Present at LSI USA '26 (GlobeNewswire)
Mar-05-26 08:45AM	Autonomix Medical Selected for Best Innovation Competition at CRT 2026 (GlobeNewswire)
Mar-04-26 08:40AM	Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis (GlobeNewswire)
Feb-25-26 08:30AM	Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation (GlobeNewswire) +7.98%
Feb-19-26 08:30AM	Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation (GlobeNewswire)
Jan-28-26 08:30AM	Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting (GlobeNewswire)
Jan-09-26 08:45AM	Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium (GlobeNewswire)
Dec-30-25 08:30AM	Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology (GlobeNewswire) +8.33%
Dec-23-25 08:45AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment (GlobeNewswire) -6.95%
Dec-18-25 08:30AM	Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (GlobeNewswire)
Nov-26-25 08:45AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth (GlobeNewswire) +10.19%
Nov-18-25 08:30AM	Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules (GlobeNewswire) -17.38%
Nov-17-25 08:00AM	Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study (GlobeNewswire) +58.18%
Oct-24-25 09:00AM	Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Conference (GlobeNewswire)
09:15AM	Loading…
Oct-16-25 09:15AM	Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit (GlobeNewswire)
Oct-09-25 08:45AM	Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology (GlobeNewswire)
Oct-02-25 08:45AM	Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Sep-29-25 09:15AM	Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System (GlobeNewswire)
Sep-09-25 09:00AM	Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress (GlobeNewswire)
Sep-04-25 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment (GlobeNewswire) -8.90%
07:00AM	Innovation and IP in Medtech Stocks - How Patents Build Leaders (Newsfile)
Sep-03-25 08:30AM	Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study (GlobeNewswire)
Sep-02-25 08:30AM	Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire) +10.71%
Aug-20-25 08:30AM	Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology (GlobeNewswire)
Aug-18-25 09:15AM	Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc. (GlobeNewswire)
Aug-15-25 09:00AM	Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech (GlobeNewswire)
Aug-14-25 08:30AM	Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies (GlobeNewswire)
Jul-31-25 12:00PM	Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why (Zacks) +9.09%
Jul-22-25 08:45AM	Autonomix Medical, Inc. Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference (GlobeNewswire) -24.04%
08:40AM	JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live (ACCESSWIRE)
08:30AM	Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds (GlobeNewswire)
Jul-21-25 08:45AM	Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications (GlobeNewswire) +15.82%
Jul-07-25 08:30AM	Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Jun-30-25 08:30AM	Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase ("PoC 2") of Proof-of-Concept Human Clinical Study (GlobeNewswire) -21.89%
Jun-27-25 08:00AM	Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology (GlobeNewswire) +60.80%
Jun-05-25 08:45AM	Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain (GlobeNewswire) -15.85%
May-22-25 11:39AM	AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech (Zacks)
May-15-25 08:30AM	Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology (GlobeNewswire) +9.20%
May-14-25 09:20AM	Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event (GlobeNewswire) -5.95%
May-13-25 09:20AM	Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market (GlobeNewswire) +5.71%
May-05-25 08:30AM	Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain (GlobeNewswire)
May-01-25 09:25AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain (GlobeNewswire)
Apr-30-25 08:15AM	Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain (GlobeNewswire) -7.51%
Apr-24-25 08:30AM	Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR (GlobeNewswire)
Apr-17-25 05:00PM	Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-16-25 08:30AM	Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology (GlobeNewswire) +5.99%
Apr-08-25 08:15AM	Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain (GlobeNewswire)
Apr-03-25 08:30AM	Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) (GlobeNewswire)
Mar-21-25 05:00PM	Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -9.13%
Mar-20-25 08:30AM	Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology (GlobeNewswire) +10.61%
Mar-14-25 08:30AM	Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation (GlobeNewswire) -9.76%
Mar-06-25 09:00AM	Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (GlobeNewswire)
Feb-26-25 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit (GlobeNewswire)
Feb-20-25 08:30AM	Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting (GlobeNewswire)
Feb-19-25 09:00AM	Autonomix Medical, Inc. Participates in the Virtual Investor Top 5 for '25 On-Demand Conference (GlobeNewswire)
Feb-13-25 08:00AM	Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jan-24-25 08:45AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Jan-17-25 08:00AM	Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) +9.79%
Jan-15-25 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +10.55%
Jan-13-25 08:30AM	Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting (GlobeNewswire) -8.65%
Dec-30-24 08:30AM	Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology (GlobeNewswire) +20.61%
Dec-23-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Dec-19-24 08:30AM	Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality (GlobeNewswire) -5.06%
Dec-05-24 08:30AM	Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) -6.72%
Nov-25-24 04:00PM	Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option (GlobeNewswire) -5.21%
Nov-22-24 09:15AM	Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering (GlobeNewswire) -53.55%
Nov-11-24 08:00AM	Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Oct-31-24 08:00AM	Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction (GlobeNewswire) +39.75%
Oct-30-24 08:30AM	Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
Oct-28-24 08:00AM	Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial (GlobeNewswire) +60.57%
Oct-25-24 11:30AM	Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th (GlobeNewswire) -22.12%
Oct-22-24 08:30AM	Autonomix Announces Reverse Stock Split (GlobeNewswire)
Oct-08-24 08:30AM	Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC (GlobeNewswire)
Oct-03-24 08:35AM	This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer (News Direct)
Sep-26-24 07:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Sep-20-24 08:30AM	Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum (GlobeNewswire)
Sep-09-24 07:00AM	Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients (GlobeNewswire) +9.09%
Aug-27-24 08:30AM	Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-21-24 08:30AM	Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress (GlobeNewswire)
Aug-13-24 08:00AM	Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones (GlobeNewswire)
Aug-02-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire) -23.30%
Jul-24-24 08:00AM	Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology (GlobeNewswire)
Jul-22-24 09:05AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +9.22%
Jul-18-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor What This Means Segment Covering Technology License Agreement (GlobeNewswire) +10.66%

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in The Woodlands, TX.

CEO & PresidentMr. Bradley Hauser

Executive Vice ChairmanMs. Lori H. Bisson

Co-Founder & Independent DirectorMr. David A. Robins

Chief Financial OfficerMr. Trent N. Smith CPA

Executive ChairmanMr. Walter V. Klemp

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMIX

Autonomix Medical Inc

Upgrade your Finviz experience